Psychedelic Spotlight: Three Phase 3 Clinical Trials that Could Legalize Psychedelics

Summary: When will psychedelics become legal in the U.S.?

Psychedelic Spotlight explores how three different clinical trials “have the best chances to legalize psychedelics for therapy.”

“Unlike the others on this list, using MDMA-assisted therapy to treat PTSD is already in its second Phase 3 trial. The nonprofit MAPS —the leading institution driving research into psychedelics as medicines— completed its first Phase 3 trial in 2021,” writes James Hallifax of Psychedelic Spotlight.

Originally appearing here (Archived)